Publikationen in Zusammenarbeit mit Forschern von Hadassah Medical Center (1)

2019

  1. Cardiovascular safety of oral semaglutide in patients with type 2 diabetes: Rationale, design and patient baseline characteristics for the PIONEER 6 trial

    Diabetes, Obesity and Metabolism, Vol. 21, Núm. 3, pp. 499-508